Prevention, preparedness, response to top G20 health group agenda
HQ Team April 17, 2023: Health emergencies, prevention, preparedness, and response, will top the agenda at the secondĀ Health Working GroupĀ meeting of G20 member.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 17, 2023: Health emergencies, prevention, preparedness, and response, will top the agenda at the secondĀ Health Working GroupĀ meeting of G20 member.
HQ Team April 14, 2023: Women, who account for one-third of those employed in the agricultural sector, are paid about 20% less than.
HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.
HQ Team April 13, 2023: Alphabet Inc, Google’s parent company, has signed two new power purchase agreements in Belgium and the Netherlands to.
HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid.
HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.
HQ Team April 12, 2023: About 263 million children and young people worldwide are out of school, and achieving education for all by.
HQ Team April 12, 2023: A 56-year-old woman from China’s Guangdong province died on March 16 after being infected with avian influenza, AH3N8,.
HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.
HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based companyās Galvus brand for.